ArticleBMJ open2024

Is it feasible to treat polycystic ovarian syndrome with or without insulin resistance using glucokinase activators as novel hypoglycaemic medications? A protocol for a systematic review and meta-analysis.

Genping Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.